While not as dramatic as China’s abandonment of the zero-COVID policy in late 2022, the underlying reasons for the surprising ...

The dramatic stimulus-fueled rally in Chinese stocks has cost traders betting against US-listed shares roughly $6.9 billion in mark-to-market losses, according to a report from S3 Partners.

In the Melbourne CBD market hit hard by the pandemic, some office vendors hope high replacement costs make their existing ...

Last week, Chinese stock markets had their best week since 2008 after the country unleashed a series of stimulus measures, ...